Psoriatic Arthritis Treatment Market Size, Share & COVID-19 Impact Analysis, By Drugs Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI101066

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Psoriatic Arthritis for Key Countries/Region
2. Recent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.
3. Pipeline Analysis for Key Companies
4. Regulatory Framework by Key Countries
5. Impact of COVID-19 on Psoriatic Arthritis Treatment Market
Global Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
  3. Biologic Disease Modifying Anti-Rheumatic Drugs
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
  3. Biologic Disease Modifying Anti-Rheumatic Drugs
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online pharmacies
5. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Non-steroidal Anti-inflammatory Drugs
  2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
  3. Biologic Disease Modifying Anti-Rheumatic Drugs
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online pharmacies
5. Market Analysis – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
  3. Biologic Disease Modifying Anti-Rheumatic Drugs
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online pharmacies
5. Market Analysis – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
  3. Biologic Disease Modifying Anti-Rheumatic Drugs
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online pharmacies
5. Market Analysis – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  2. Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
  3. Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online pharmacies
5. Market Analysis – By Country/Sub-region
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2025)
3. Company Profiles (Overview, Products, SWOT, Recent developments, strategies, financials (based on availability))
  1. AbbVie Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  2. Novartis AG
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  3. Johnson & Johnson Services, Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  4. Pfizer Inc.,
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  5. LEO Pharma A/S
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  6. Merck & Co., Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  7. Amgen Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  8. Eli Lilly and Company
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  9. CELGENE CORPORATION
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  10. UCB S.A.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  11. Sun Pharmaceutical Industries Ltd.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  12. Other prominent players
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
Strategic Recommendations

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Psoriatic Arthritis for Key Countries/Region
2. Recent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.
3. Pipeline Analysis for Key Companies
4. Regulatory Framework by Key Countries
5. Impact of COVID-19 on Psoriatic Arthritis Treatment Market
Global Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
  3. Biologic Disease Modifying Anti-Rheumatic Drugs
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
  3. Biologic Disease Modifying Anti-Rheumatic Drugs
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online pharmacies
5. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Non-steroidal Anti-inflammatory Drugs
  2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
  3. Biologic Disease Modifying Anti-Rheumatic Drugs
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online pharmacies
5. Market Analysis – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
  3. Biologic Disease Modifying Anti-Rheumatic Drugs
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online pharmacies
5. Market Analysis – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
  3. Biologic Disease Modifying Anti-Rheumatic Drugs
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online pharmacies
5. Market Analysis – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  2. Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
  3. Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
4. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online pharmacies
5. Market Analysis – By Country/Sub-region
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2025)
3. Company Profiles (Overview, Products, SWOT, Recent developments, strategies, financials (based on availability))
  1. AbbVie Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  2. Novartis AG
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  3. Johnson & Johnson Services, Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  4. Pfizer Inc.,
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  5. LEO Pharma A/S
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  6. Merck & Co., Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  7. Amgen Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  8. Eli Lilly and Company
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  9. CELGENE CORPORATION
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  10. UCB S.A.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  11. Sun Pharmaceutical Industries Ltd.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  12. Other prominent players
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
Strategic Recommendations

Read Less

List of Figures

Figure 1: Global Psoriatic Arthritis Treatment Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034

Figure 2: Global Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2025 & 2034

Figure 3: Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Non-Steroidal Anti-inflammatory Drugs (NSAIDS), 2021-2034

Figure 4: Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Non-Biologic Disease Modifying Anti-Rheumatic Drugs, 2021-2034

Figure 5: Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Biologic Disease Modifying Anti-Rheumatic Drugs, 2021-2034

Figure 6: Global Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2025 & 2034

Figure 7: Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Oral, 2021-2034

Figure 8: Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Parenteral, 2021-2034

Figure 9: Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Topical, 2021-2034

Figure 10: Global Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 11: Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Hospital Pharmacies, 2021-2034

Figure 12: Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Retail Pharmacies, 2021-2034

Figure 13: Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Online Pharmacies, 2021-2034

Figure 14: Global Psoriatic Arthritis Treatment Market Value (USD Billion), by Region, 2025 & 2034

Figure 15: North America Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2025 & 2034

Figure 16: North America Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2025

Figure 17: North America Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2025 & 2034

Figure 18: North America Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 19: North America Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 20: North America Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 21: North America Psoriatic Arthritis Treatment Market Value (USD Billion), By Country, 2025 & 2034

Figure 22: North America Psoriatic Arthritis Treatment Market Value Share (%), By Country, 2025

Figure 23: Europe Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2025 & 2034

Figure 24: Europe Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2025

Figure 25: Europe Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2025 & 2034

Figure 26: Europe Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 27: Europe Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 28: Europe Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 29: Europe Psoriatic Arthritis Treatment Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 30: Europe Psoriatic Arthritis Treatment Market Value Share (%), By Country/ Sub-region, 2025

Figure 31: Asia Pacific Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2025 & 2034

Figure 32: Asia Pacific Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2025

Figure 33: Asia Pacific Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2025 & 2034

Figure 34: Asia Pacific Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 35: Asia Pacific Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 36: Asia Pacific Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 37: Asia Pacific Psoriatic Arthritis Treatment Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 38: Asia Pacific Psoriatic Arthritis Treatment Market Value Share (%), By Country/ Sub-region, 2025

Figure 39: Latin America Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2025 & 2034

Figure 40: Latin America Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2025

Figure 41: Latin America Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2025 & 2034

Figure 42: Latin America Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 43: Latin America Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 44: Latin America Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 45: Latin America Psoriatic Arthritis Treatment Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 46: Latin America Psoriatic Arthritis Treatment Market Value Share (%), By Country/ Sub-region, 2025

Figure 47: Middle East & Africa Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2025 & 2034

Figure 48: Middle East & Africa Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2025

Figure 49: Middle East & Africa Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2025 & 2034

Figure 50: Middle East & Africa Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 51: Middle East & Africa Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 52: Middle East & Africa Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 53: Middle East & Africa Psoriatic Arthritis Treatment Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 54: Middle East & Africa Psoriatic Arthritis Treatment Market Value Share (%), By Country/ Sub-region, 2025

Figure 55: Global Psoriatic Arthritis Treatment Market Share (%), By Company, 2025

List of Tables

Table 1: Global Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2021–2034

Table 2: Global Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2021–2034

Table 3: Global Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021–2034

Table 4: Global Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Region, 2021-2034

Table 5: North America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034

Table 6: North America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 7: North America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 8: North America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country, 2021-2034

Table 9: Europe Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034

Table 10: Europe Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 11: Europe Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 12: Europe Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 13: Asia Pacific Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034

Table 14: Asia Pacific Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 15: Asia Pacific Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 16: Asia Pacific Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 17: Latin America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034

Table 18: Latin America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 19: Latin America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 20: Latin America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 21: Middle East & Africa Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034

Table 22: Middle East & Africa Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 23: Middle East & Africa Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 24: Middle East & Africa Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 160

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com